These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 18834941

  • 21. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L, Thiébaut R, Carron JC, Moreau JF, Merville P, Taupin JL.
    Transplantation; 2008 Oct 27; 86(8):1060-7. PubMed ID: 18946343
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial.
    Shenoy S, Hardinger KL, Crippin J, Desai N, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Transplantation; 2007 May 27; 83(10):1389-92. PubMed ID: 17519792
    [Abstract] [Full Text] [Related]

  • 23. Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis.
    Ekong UD, Mathew J, Melin-Aldana H, Wang D, Alonso EM.
    Pediatr Transplant; 2012 Mar 27; 16(2):165-75. PubMed ID: 22360400
    [Abstract] [Full Text] [Related]

  • 24. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C.
    Transplant Proc; 2009 Mar 27; 41(2):756-63. PubMed ID: 19328973
    [Abstract] [Full Text] [Related]

  • 25. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
    Yi T, Cuchara L, Wang Y, Koh KP, Ranjbaran H, Tellides G, Pober JS, Lorber MI.
    Transplantation; 2006 Feb 27; 81(4):559-66. PubMed ID: 16495804
    [Abstract] [Full Text] [Related]

  • 26. Conversion to sirolimus in renal transplant patients with tumors.
    Sánchez-Fructuoso A, Conesa J, Perez Flores I, Ridao N, Calvo N, Prats D, Rodríguez A, Barrientos A.
    Transplant Proc; 2006 Oct 27; 38(8):2451-2. PubMed ID: 17097964
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic variability of sirolimus in Taiwanese renal transplant recipients.
    Chueh SC, Wang SM, Lai MK, Chen J.
    Transplant Proc; 2004 Sep 27; 36(7):2058-9. PubMed ID: 15518745
    [Abstract] [Full Text] [Related]

  • 28. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F, Di Sandro S, De Ruvo N, Spaggiari M, Montalti R, Ballarin R, Cappelli G, Gerunda GE.
    J Clin Gastroenterol; 2009 Mar 27; 43(3):280-6. PubMed ID: 19057397
    [Abstract] [Full Text] [Related]

  • 29. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients.
    Li Y, Shi Y, Liao Y, Yan L, Zhang Q, Wang L.
    Int Immunopharmacol; 2015 Sep 27; 28(1):435-43. PubMed ID: 26186486
    [Abstract] [Full Text] [Related]

  • 30. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS, Ruiz JC, Izquierdo M, Fernández-Fresnedo G, Gómez-Alamillo C, Merino R, Benito MJ, Cacho E, Rodrigo E, Palomar R, López-Hoyos M, Arias M.
    Transplantation; 2006 Aug 27; 82(4):550-7. PubMed ID: 16926600
    [Abstract] [Full Text] [Related]

  • 31. Sirolimus therapy in liver transplant patients: an initial experience at a single center.
    Nocera A, Andorno E, Tagliamacco A, Morelli N, Bottino G, Ravazzoni F, Casaccia M, Barocci S, Alice S, Santori G, Ghirelli R, Valente U.
    Transplant Proc; 2008 Aug 27; 40(6):1950-2. PubMed ID: 18675098
    [Abstract] [Full Text] [Related]

  • 32. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH, Russ GR, Chadban SJ, Campbell S, McDonald SP.
    Nephrology (Carlton); 2008 Apr 27; 13(2):171-6. PubMed ID: 18275507
    [Abstract] [Full Text] [Related]

  • 33. Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients.
    Morard I, Dumortier J, Spahr L, Hadengue A, Majno P, Morel P, Mentha G, Giostra E.
    Liver Transpl; 2007 May 27; 13(5):658-64. PubMed ID: 17457887
    [Abstract] [Full Text] [Related]

  • 34. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies.
    Mathew T, Kreis H, Friend P.
    Clin Transplant; 2004 Aug 27; 18(4):446-9. PubMed ID: 15233824
    [Abstract] [Full Text] [Related]

  • 35. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
    Ori Y, Herman-Edelstein M, Zingerman B, Rozen-Zvi B, Gafter U, Malachi T, Gafter-Gvili A.
    Biomed Pharmacother; 2012 Sep 27; 66(6):409-13. PubMed ID: 22795807
    [Abstract] [Full Text] [Related]

  • 36. Sirolimus in liver transplant recipients: a large single-center experience.
    Vivarelli M, Dazzi A, Cucchetti A, Gasbarrini A, Zanello M, Di Gioia P, Bianchi G, Tamè MR, Gaudio MD, Ravaioli M, Cescon M, Grazi GL, Pinna AD.
    Transplant Proc; 2010 Sep 27; 42(7):2579-84. PubMed ID: 20832548
    [Abstract] [Full Text] [Related]

  • 37. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
    Chu ZQ, Ji Q.
    Transplant Proc; 2013 Sep 27; 45(1):153-6. PubMed ID: 23375290
    [Abstract] [Full Text] [Related]

  • 38. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R, Pastor MC, Bayes B, Malumbres S, Homs M, Llopis MA, Bonet J, Romero R.
    Transplant Proc; 2007 Sep 27; 39(7):2170-2. PubMed ID: 17889127
    [Abstract] [Full Text] [Related]

  • 39. Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.
    Schachter AD, Benfield MR, Wyatt RJ, Grimm PC, Fennell RS, Herrin JT, Lirenman DS, McDonald RA, Munoz-Arizpe R, Harmon WE.
    Pediatr Transplant; 2006 Dec 27; 10(8):914-9. PubMed ID: 17096757
    [Abstract] [Full Text] [Related]

  • 40. The effect of sirolimus in the development of chronic allograft nephropathy.
    Gürkan A, Kaçar S, Erdoğdu U, Varilsüha C, Kandemir G, Karaca C, Akman F.
    Transplant Proc; 2008 Dec 27; 40(1):114-6. PubMed ID: 18261561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.